MAIA Biotechnology, Inc. (MAIA:NYSEMKT) closed at $1.15 on October 23, 2026, up 1.77% on the day. The stock trades 63.9% below its 52-week high of $3.19 and 32.2% above its 52-week low of $0.870. Over the past year, it lost 19.6%. MAIA Biotechnology, Inc. is part of the Health Care sector.
In 252 trading sessions since October 23, 2025, MAIA closed higher on 115 days (46%). Its best day was January 20, 2026 (+26.44%) and its worst was March 3, 2026 (-27.05%). The stock moved 10% or more in a single session 12 times. It opened at least 5% above the previous day's high 2 times.
MAIA Biotechnology Inc is a targeted therapy, immuno-oncology company focused on the development and commercialization of potential first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's lead program is THIO, a potential first-in-class cancer telomere targeting agent in clinical development for the treatment of telomerase-positive cancer cells.
Find more stocks like MAIA with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.